Bevacizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Mongolian Patients with Diabetic Macular Edema
Central Asian Journal of Medical Sciences · 2016
DOI: 10.24079/cajms.2016.01.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central Asian Journal of Medical Sciences, 2016. Verfasst von Anaraa Toishubai und 14 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objectives
To evaluate the efficacy and safety of bevacizumab monotherapy and bevacizumab therapy combined with laser therapy versus laser monotherapy in Mongolian patients with visual impairment due to diabetic macular edema (DME).
Methods
One hundred twelve eligible patients, aged ^18 years, with type 1 or 2 diabetes mellitus and best corrected visual acuity (BCVA) in the study eye of 35 to 69 Early Treatment Diabetic Retinopathy Study letters at 4 m (Snellen equivalent: >6/60 or 10 and >15 letters and had a BCVA letter score >73 (Snellen equivalent: >6/12) with bevacizumab monotherapy (23.8% and 7.1% and 4.8%, respectively) and bevacizumab + laser (57.1% and 28.6% and 14.3%, respectively) versus laser monotherapy (0% and 0% and 0%, respectively). The mean central retinal subfield thickness was significantly reduced from baseline to month 12 with bevacizumab (-124.4 pm) and bevacizumab + laser (-129.0 pm) versus laser (-62.0 pm; both p = 0.002). Conjunctival hemorrhage was the most common ocular event. No endophthalmitis cases occurred.
Conclusion
Bevacizumab monotherapy or bevacizumab + laser showed superior BCVA improvements over macular laser treatment alone in Mongolian patients with visual impairment due to DME.
Zitieren
APA
Toishubai, A., Davaatseren, U., Jamyanjav, B., Lim, S. T., Tuvaan, B., Tsengenbayar, M., Batbileg, M., Luvsantseren, O., Jamyansuren, U., Munkhkhuyag, M., Bayaraa, U., Nanjid, K., Muktar, Y., Chandaga, U., & Ochir, C. (2016). Bevacizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Mongolian Patients with Diabetic Macular Edema. Central Asian Journal of Medical Sciences. https://doi.org/10.24079/cajms.2016.01.008
Vancouver
Toishubai A, Davaatseren U, Jamyanjav B, Lim ST, Tuvaan B, Tsengenbayar M, et al. Bevacizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Mongolian Patients with Diabetic Macular Edema. Central Asian Journal of Medical Sciences. 2016. doi:10.24079/cajms.2016.01.008
BibTeX
@article{Toishubai2016,
author = {Toishubai, Anaraa and Davaatseren, Uranchimeg and Jamyanjav, Baasankhuu and Lim, Sun Taek and Tuvaan, Bulgan and Tsengenbayar, Munkhzaya and Batbileg, Munkhkhishig and Luvsantseren, Oyunzaya and Jamyansuren, Urangua and Munkhkhuyag, Munkhsaikhan and Bayaraa, Unudeleg and Nanjid, Khudrenchuluun and Muktar, Yerkyebulan and Chandaga, Unurtsetseg and Ochir, Chimedsuren},
title = {Bevacizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Mongolian Patients with Diabetic Macular Edema},
journal = {Central Asian Journal of Medical Sciences},
year = {2016},
doi = {10.24079/cajms.2016.01.008}
}
EUVIMED